
Four-Year Efficacy and Safety Data of Ustekinumab Use in Ulcerative Colitis
David P. Hudesman, shares insight on long-term extension data and clinical implications from ACG 2022 on the use of ustekinumab for the management of ulcerative colitis.
The HCPLive Special Report page is a resource for live video interviews with leading clinical experts and investigators from major medical conferences and events throughout the year.

David P. Hudesman, shares insight on long-term extension data and clinical implications from ACG 2022 on the use of ustekinumab for the management of ulcerative colitis.

Insight from gastroenterology specialists on implications for treating patients with ulcerative colitis with newer novel therapies as recently presented at DDW 2021.

